Chellappa Stalin, Hugenschmidt Harald, Hagness Morten, Line Pål D, Labori Knut J, Wiedswang Gro, Taskén Kjetil, Aandahl Einar M
Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway; Biotechnology Center, University of Oslo, Oslo, Norway; K.G. Jebsen Inflammation Research Center, University of Oslo, Oslo, Norway; K.G. Jebsen Center for Cancer Immunotherapy, University of Oslo, Oslo, Norway.
Section for Transplantation Surgery, Oslo University Hospital, Oslo, Norway; Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway.
Oncoimmunology. 2015 Oct 29;5(4):e1102828. doi: 10.1080/2162402X.2015.1102828. eCollection 2016 Apr.
Pancreatic ductal adenocarcinoma (PDAC) is highly infiltrated by CD4T cells that express RORγt and IL-17 (T17). Compelling evidence from the tumor microenvironment suggest that regulatory T cells (T) contribute to T17 mediated inflammation. Concurrently, PDAC patients have elevated levels of pro-inflammatory cytokines that may lead to T17 associated functional plasticity in T. In this study, we investigated the phenotype and functional properties of T in patients with PDAC. We report that PDAC patients have elevated frequency of FOXP3T, which exclusively occurred within the FOXP3RORγtT compartment. The FOXP3RORγtT retained FOXP3T markers and represented an activated subset. The expression of RORγt in T may indicate a phenotypic switch toward T17 cells. However, the FOXP3RORγtT produced both T17 and T2 associated pro-inflammatory cytokines, which corresponded with elevated T17 and T2 immune responses in PDAC patients. Both the FOXP3T and FOXP3RORγtT from PDAC patients strongly suppressed T cell immune responses, but they had impaired anti-inflammatory properties. We conclude that FOXP3RORγtT have a dual phenotype with combined pro-inflammatory and immunosuppressive activity, which may be involved in the pathogenesis of PDAC.
胰腺导管腺癌(PDAC)被表达RORγt和白细胞介素-17(T17)的CD4 T细胞高度浸润。来自肿瘤微环境的有力证据表明,调节性T细胞(Treg)促成了T17介导的炎症。同时,PDAC患者促炎细胞因子水平升高,这可能导致Treg出现与T17相关的功能可塑性。在本研究中,我们调查了PDAC患者中Treg的表型和功能特性。我们报告称,PDAC患者中FOXP3 + Treg频率升高,且仅出现在FOXP3 + RORγt + Treg亚群中。FOXP3 + RORγt + Treg保留了FOXP3 + Treg标志物,并代表一个活化亚群。Treg中RORγt的表达可能表明其向T17细胞的表型转变。然而,FOXP3 + RORγt + Treg产生了与T17和T2相关的促炎细胞因子,这与PDAC患者中升高的T17和T2免疫反应相对应。来自PDAC患者的FOXP3 + Treg和FOXP3 + RORγt + Treg均强烈抑制T细胞免疫反应,但它们的抗炎特性受损。我们得出结论,FOXP3 + RORγt + Treg具有促炎和免疫抑制活性相结合的双重表型,这可能参与了PDAC的发病机制。